Compile Data Set for Download or QSAR
Report error Found 35 Enz. Inhib. hit(s) with all data for entry = 10937
TargetAutotaxin(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM50557594(CHEMBL4788435 | US11485727, Example 1.3)
Affinity DataIC50: 1.5nMAssay Description:5 nM recombinant ATX (Cayman Chemicals) was supplemented to 50 mM Tris buffer (pH 8.0) containing 3 mM KCl, 1 mM CaCl2, 1 mM MgCl2 0.14 mM NaCl, and ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM50557595(CHEMBL4745566 | US11485727, Example 1.7)
Affinity DataIC50: 1.60nMAssay Description:5 nM recombinant ATX (Cayman Chemicals) was supplemented to 50 mM Tris buffer (pH 8.0) containing 3 mM KCl, 1 mM CaCl2, 1 mM MgCl2 0.14 mM NaCl, and ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM50557599(CHEMBL4751395 | US11485727, Example 2.10)
Affinity DataIC50: 1.80nMAssay Description:5 nM recombinant ATX (Cayman Chemicals) was supplemented to 50 mM Tris buffer (pH 8.0) containing 3 mM KCl, 1 mM CaCl2, 1 mM MgCl2 0.14 mM NaCl, and ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM50557597(CHEMBL4758133 | US11485727, Example 2.6)
Affinity DataIC50: 1.80nMAssay Description:5 nM recombinant ATX (Cayman Chemicals) was supplemented to 50 mM Tris buffer (pH 8.0) containing 3 mM KCl, 1 mM CaCl2, 1 mM MgCl2 0.14 mM NaCl, and ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM50557598(CHEMBL4784419 | US11485727, Example 2.7)
Affinity DataIC50: 1.90nMAssay Description:5 nM recombinant ATX (Cayman Chemicals) was supplemented to 50 mM Tris buffer (pH 8.0) containing 3 mM KCl, 1 mM CaCl2, 1 mM MgCl2 0.14 mM NaCl, and ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM50557596(CHEMBL4743845 | US11485727, Example 2.4)
Affinity DataIC50: 1.90nMAssay Description:5 nM recombinant ATX (Cayman Chemicals) was supplemented to 50 mM Tris buffer (pH 8.0) containing 3 mM KCl, 1 mM CaCl2, 1 mM MgCl2 0.14 mM NaCl, and ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM191570(US9670204, 12 2-((2-ethyl-8-fluoro-6-(4-(2-(3-hydr...)
Affinity DataIC50: 2nMAssay Description:5 nM recombinant ATX (Cayman Chemicals) was supplemented to 50 mM Tris buffer (pH 8.0) containing 3 mM KCl, 1 mM CaCl2, 1 mM MgCl2 0.14 mM NaCl, and ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM579837(US11485727, Example 2.8)
Affinity DataIC50: 2nMAssay Description:5 nM recombinant ATX (Cayman Chemicals) was supplemented to 50 mM Tris buffer (pH 8.0) containing 3 mM KCl, 1 mM CaCl2, 1 mM MgCl2 0.14 mM NaCl, and ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM579832(US11485727, Example 2.3)
Affinity DataIC50: 2.20nMAssay Description:5 nM recombinant ATX (Cayman Chemicals) was supplemented to 50 mM Tris buffer (pH 8.0) containing 3 mM KCl, 1 mM CaCl2, 1 mM MgCl2 0.14 mM NaCl, and ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM579844(US11485727, Example 2.15)
Affinity DataIC50: 2.20nMAssay Description:5 nM recombinant ATX (Cayman Chemicals) was supplemented to 50 mM Tris buffer (pH 8.0) containing 3 mM KCl, 1 mM CaCl2, 1 mM MgCl2 0.14 mM NaCl, and ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM579830(N-methyl-N-[1-(4-{[(6-{[6-(trifluoromethyl)pyridin...)
Affinity DataIC50: 2.30nMAssay Description:5 nM recombinant ATX (Cayman Chemicals) was supplemented to 50 mM Tris buffer (pH 8.0) containing 3 mM KCl, 1 mM CaCl2, 1 mM MgCl2 0.14 mM NaCl, and ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM579848(US11485727, Example 2.19)
Affinity DataIC50: 2.40nMAssay Description:5 nM recombinant ATX (Cayman Chemicals) was supplemented to 50 mM Tris buffer (pH 8.0) containing 3 mM KCl, 1 mM CaCl2, 1 mM MgCl2 0.14 mM NaCl, and ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM579850(US11485727, Example 2.21)
Affinity DataIC50: 2.40nMAssay Description:5 nM recombinant ATX (Cayman Chemicals) was supplemented to 50 mM Tris buffer (pH 8.0) containing 3 mM KCl, 1 mM CaCl2, 1 mM MgCl2 0.14 mM NaCl, and ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM579834(US11485727, Example 2.5)
Affinity DataIC50: 2.5nMAssay Description:5 nM recombinant ATX (Cayman Chemicals) was supplemented to 50 mM Tris buffer (pH 8.0) containing 3 mM KCl, 1 mM CaCl2, 1 mM MgCl2 0.14 mM NaCl, and ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM579849(US11485727, Example 2.20)
Affinity DataIC50: 2.90nMAssay Description:5 nM recombinant ATX (Cayman Chemicals) was supplemented to 50 mM Tris buffer (pH 8.0) containing 3 mM KCl, 1 mM CaCl2, 1 mM MgCl2 0.14 mM NaCl, and ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM579853(1-[4-(4-{[(6-{[6-(Difluoromethyl)pyridin-3-yl]meth...)
Affinity DataIC50: 2.90nMAssay Description:5 nM recombinant ATX (Cayman Chemicals) was supplemented to 50 mM Tris buffer (pH 8.0) containing 3 mM KCl, 1 mM CaCl2, 1 mM MgCl2 0.14 mM NaCl, and ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM579824(US11485727, Example 1.2)
Affinity DataIC50: 2.90nMAssay Description:5 nM recombinant ATX (Cayman Chemicals) was supplemented to 50 mM Tris buffer (pH 8.0) containing 3 mM KCl, 1 mM CaCl2, 1 mM MgCl2 0.14 mM NaCl, and ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM579831(US11485727, Example 2.2)
Affinity DataIC50: 3nMAssay Description:5 nM recombinant ATX (Cayman Chemicals) was supplemented to 50 mM Tris buffer (pH 8.0) containing 3 mM KCl, 1 mM CaCl2, 1 mM MgCl2 0.14 mM NaCl, and ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM579826(US11485727, Example 1.4)
Affinity DataIC50: 3.30nMAssay Description:5 nM recombinant ATX (Cayman Chemicals) was supplemented to 50 mM Tris buffer (pH 8.0) containing 3 mM KCl, 1 mM CaCl2, 1 mM MgCl2 0.14 mM NaCl, and ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM579823(3-{[6-(Difluoromethyl)pyridin-3-yl]methoxy}-6-iodo...)
Affinity DataIC50: 3.40nMAssay Description:5 nM recombinant ATX (Cayman Chemicals) was supplemented to 50 mM Tris buffer (pH 8.0) containing 3 mM KCl, 1 mM CaCl2, 1 mM MgCl2 0.14 mM NaCl, and ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM579841(US11485727, Example 2.12)
Affinity DataIC50: 3.5nMAssay Description:5 nM recombinant ATX (Cayman Chemicals) was supplemented to 50 mM Tris buffer (pH 8.0) containing 3 mM KCl, 1 mM CaCl2, 1 mM MgCl2 0.14 mM NaCl, and ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM579838(US11485727, Example 2.9)
Affinity DataIC50: 3.70nMAssay Description:5 nM recombinant ATX (Cayman Chemicals) was supplemented to 50 mM Tris buffer (pH 8.0) containing 3 mM KCl, 1 mM CaCl2, 1 mM MgCl2 0.14 mM NaCl, and ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM579840(US11485727, Example 2.11)
Affinity DataIC50: 3.80nMAssay Description:5 nM recombinant ATX (Cayman Chemicals) was supplemented to 50 mM Tris buffer (pH 8.0) containing 3 mM KCl, 1 mM CaCl2, 1 mM MgCl2 0.14 mM NaCl, and ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM579827(US11485727, Example 1.5)
Affinity DataIC50: 3.90nMAssay Description:5 nM recombinant ATX (Cayman Chemicals) was supplemented to 50 mM Tris buffer (pH 8.0) containing 3 mM KCl, 1 mM CaCl2, 1 mM MgCl2 0.14 mM NaCl, and ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM579852(US11485727, Example 2.23)
Affinity DataIC50: 3.90nMAssay Description:5 nM recombinant ATX (Cayman Chemicals) was supplemented to 50 mM Tris buffer (pH 8.0) containing 3 mM KCl, 1 mM CaCl2, 1 mM MgCl2 0.14 mM NaCl, and ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM579842(US11485727, Example 2.13)
Affinity DataIC50: 4nMAssay Description:5 nM recombinant ATX (Cayman Chemicals) was supplemented to 50 mM Tris buffer (pH 8.0) containing 3 mM KCl, 1 mM CaCl2, 1 mM MgCl2 0.14 mM NaCl, and ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM579843(US11485727, Example 2.14)
Affinity DataIC50: 4.40nMAssay Description:5 nM recombinant ATX (Cayman Chemicals) was supplemented to 50 mM Tris buffer (pH 8.0) containing 3 mM KCl, 1 mM CaCl2, 1 mM MgCl2 0.14 mM NaCl, and ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM50187686(CHEMBL3828074 | US9670204, 2 2-((2-ethyl-6-(4-(2-(...)
Affinity DataIC50: 5nMAssay Description:5 nM recombinant ATX (Cayman Chemicals) was supplemented to 50 mM Tris buffer (pH 8.0) containing 3 mM KCl, 1 mM CaCl2, 1 mM MgCl2 0.14 mM NaCl, and ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
Go to US Patent
PDB3D3D Structure (crystal)
TargetAutotaxin(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM579846(US11485727, Example 2.17)
Affinity DataIC50: 5.20nMAssay Description:5 nM recombinant ATX (Cayman Chemicals) was supplemented to 50 mM Tris buffer (pH 8.0) containing 3 mM KCl, 1 mM CaCl2, 1 mM MgCl2 0.14 mM NaCl, and ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM579851(US11485727, Example 2.22)
Affinity DataIC50: 6.20nMAssay Description:5 nM recombinant ATX (Cayman Chemicals) was supplemented to 50 mM Tris buffer (pH 8.0) containing 3 mM KCl, 1 mM CaCl2, 1 mM MgCl2 0.14 mM NaCl, and ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM579828(US11485727, Example 1.6)
Affinity DataIC50: 6.5nMAssay Description:5 nM recombinant ATX (Cayman Chemicals) was supplemented to 50 mM Tris buffer (pH 8.0) containing 3 mM KCl, 1 mM CaCl2, 1 mM MgCl2 0.14 mM NaCl, and ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM579855(1-((3aR,3bS,6aR,6bS)-5-(4-(((6-((6-(trifluoromethy...)
Affinity DataIC50: 7nMAssay Description:5 nM recombinant ATX (Cayman Chemicals) was supplemented to 50 mM Tris buffer (pH 8.0) containing 3 mM KCl, 1 mM CaCl2, 1 mM MgCl2 0.14 mM NaCl, and ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM579854(1-[(3aR,8aS)-2-(4-{[(6-{[6-(trifluoromethyl)pyridi...)
Affinity DataIC50: 8.60nMAssay Description:5 nM recombinant ATX (Cayman Chemicals) was supplemented to 50 mM Tris buffer (pH 8.0) containing 3 mM KCl, 1 mM CaCl2, 1 mM MgCl2 0.14 mM NaCl, and ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM579847(US11485727, Example 2.18)
Affinity DataIC50: 9.20nMAssay Description:5 nM recombinant ATX (Cayman Chemicals) was supplemented to 50 mM Tris buffer (pH 8.0) containing 3 mM KCl, 1 mM CaCl2, 1 mM MgCl2 0.14 mM NaCl, and ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM579845(US11485727, Example 2.16)
Affinity DataIC50: 10.4nMAssay Description:5 nM recombinant ATX (Cayman Chemicals) was supplemented to 50 mM Tris buffer (pH 8.0) containing 3 mM KCl, 1 mM CaCl2, 1 mM MgCl2 0.14 mM NaCl, and ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/6/2023
Entry Details
Go to US Patent